Literature DB >> 16207863

Infliximab and reactivation of cerebral toxoplasmosis.

Jeremy D Young, Bradford S McGwire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207863     DOI: 10.1056/NEJMc051556

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  Risks and benefits of biologic therapy for inflammatory bowel diseases.

Authors:  Geert D'Haens
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

2.  Why the International Workshops on Opportunistic Protists?

Authors:  Edna S Kaneshiro; Eduardo Dei-Cas
Journal:  Eukaryot Cell       Date:  2009-01-23

Review 3.  The occurrence and prevention of foodborne disease in vulnerable people.

Authors:  Barbara M Lund; Sarah J O'Brien
Journal:  Foodborne Pathog Dis       Date:  2011-05-11       Impact factor: 3.171

Review 4.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

5.  In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.

Authors:  Nagwa Mostafa El-Sayed; Khadiga Ahmed Ismail; Abeer Fathy Badawy; Khaled Fathy Elhasanein
Journal:  J Parasit Dis       Date:  2015-09-24

6.  Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level.

Authors:  Mona Ibrahim Ali; Wegdan Mohamed Abd El Wahab; Doaa Ahmed Hamdy; Ahmed Hassan
Journal:  J Parasit Dis       Date:  2019-03-30

7.  Critical role for the AIM2 inflammasome during acute CNS bacterial infection.

Authors:  Richa Hanamsagar; Amy Aldrich; Tammy Kielian
Journal:  J Neurochem       Date:  2014-02-19       Impact factor: 5.372

8.  Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.

Authors:  Abeer A El-Henawy; Eman Abdel Razek Hafez; Nairmen Nabih; Naglaa M Shalaby; Mervat Mashaly
Journal:  Rheumatol Int       Date:  2017-03-20       Impact factor: 2.631

9.  Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation.

Authors:  A R Pérez; G H Fontanella; A L Nocito; S Revelli; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 10.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.